FIG Nuclear SPV II LP

Melchiorre operates as a solo GP on this filing with no co-managers listed, and the absence of any prior EDGAR filings under his name suggests either early-stage fund management, a recent transition into fund sponsorship from operating roles, or prior fund activity held outside SEC filing scope—this distinction materially affects LP diligence on investment process and operational infrastructure.

The June 2026 filing date for a nuclear-focused vehicle arrives after 18+ months of legislative clarity on U.S. nuclear policy and Section 45X production credits, positioning this raise to capture LP appetite built by sector tailwinds rather than speculative positioning—the $9M target is sized for controlled deployment in a specialized subsector rather than opportunistic market-wide exposure.

Before committing, verify whether Mark Melchiorre has key-man coverage or whether his death/disability triggers fund dissolution, and confirm whether Fund I has achieved meaningful exits or remains in holding periods—a solo GP with a small second fund and no public track record creates concentration risk that must be offset by clear operational delegation and documented Fund I performance.